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Introduction {#brb3445-sec-0005}
============

There is a variety of clinical tests that diagnose a cerebral lesion affecting the upper and lower limb by identifying limb paresis as a sign of unilateral focal cerebral lesion (Anderson et al. [2005](#brb3445-bib-0002){ref-type="ref"}). Pronator drift of the upper limb and the holding test of the upper (Barré) and lower limb (Mingazzini maneuver) are the most common tests (Koehler [2000](#brb3445-bib-0004){ref-type="ref"}). In recent years, the sensitivity and specificity of different clinical tests were systematically investigated, focusing on clinical tests of the upper limb by several different studies (Teitelbaum et al. [2002](#brb3445-bib-0010){ref-type="ref"}; Amer et al. [2012](#brb3445-bib-0001){ref-type="ref"}).

In previous studies, the implementation of two simple bedside tests, namely, the forearm rolling test and the finger rolling test in addition to known clinical tests (e.g., arm holding experiment, wrist extension, tendon reflexes, finger tapping) increased the sensitivity and specificity of the identification of focal cerebral lesions (Sawyer et al. [1993](#brb3445-bib-0009){ref-type="ref"}; Ko and Verhagen [1994](#brb3445-bib-0003){ref-type="ref"}; Yamamoto [1995](#brb3445-bib-0011){ref-type="ref"}; Teitelbaum et al. [2002](#brb3445-bib-0010){ref-type="ref"}; Amer et al. [2012](#brb3445-bib-0001){ref-type="ref"}). For instance, a three test combination consisting of pronator drift, finger tap and deep tendon reflexes led to a sensitivity of 97.8% and a negative predictive value of 95.5% for a central motor lesion. Two variants of the forearm rolling test are the index finger rolling test (Yamamoto [1995](#brb3445-bib-0011){ref-type="ref"}) and the thumb rolling test (Nowak [2011](#brb3445-bib-0005){ref-type="ref"}). All these additional tests assess rapid alternating movements of more proximal muscles of the arm and shoulder. Based on the distal to proximal gradient of the cortico‐spinal system, a test assessing more distal muscles of the hand is assumed to be more sensitive to detect subtle impairments of the cerebral cortico‐spinal tract when other clinical tests are normal.

Comparably to those validated tests of upper limb function we now developed and evaluated a new clinical bedside test to detect unilateral lower limb dysfunction: the "bed cycling test" (BCT). In an observer‐blinded prospective study using videos, we analyzed the test\'s sensitivity and specificity and compared it to the leg holding test (LHT) in the supine position.

Methods {#brb3445-sec-0006}
=======

Study protocol {#brb3445-sec-0007}
--------------

All patients and control subjects underwent a detailed standardized clinical examination by experienced neurologists. The following five tests were performed and documented using videos: (1) BCT forwards; (2) BCT backwards; (3) leg holding test; (4) Babinski\'s sign; and (5) 5‐m walking test.

The BCT was performed by asking the patients or healthy control persons to close their eyes and pedal with their legs in the air backwards for 10 sec and forwards for 10 sec (see Fig. [1](#brb3445-fig-0001){ref-type="fig"}). The BCT was documented as pathological when the leg of the affected lower limb rotated significantly slower and was less coordinated or even remained stationary while the unaffected leg moved normally. This suggested a unilateral central lesion. The bed cycling test -- forwards and backwards -- was rated together as one result (pathological or non‐pathological).

![Example of a patient performing the bed cycling test (BCT) (patient no. 5). Patient is lying on his back. Both legs are flexed in the hip. The patient is asked to air cycle rapidly with eyes closed forwards for 10 sec and backwards for 10 sec (so called "bed cycling").](BRB3-6-e00445-g001){#brb3445-fig-0001}

The LHT in the supine position was tested by asking the patients and healthy control subjects to hold both legs at an angle of 90° flexed at the hip and knees for 10 sec with eyes closed. Muscle strength was graded out of five using the Medical Research Council (MRC) scale (Palo Alto [1978](#brb3445-bib-0007){ref-type="ref"}; Paternostro‐Sluga et al. [2008](#brb3445-bib-0008){ref-type="ref"}).

Randomization and allocation to groups and rating videos {#brb3445-sec-0008}
--------------------------------------------------------

There were three videos of each study patient: one video showing only the bed cycling test (BCT), one video showing only the LHT and one video containing both clinical tests (the BCT and the LHT) resulting in 360 different videos. The 120 study participants were randomly assigned to three groups of 40 patients each. From this material we compiled the three rating videos, each consisting of BCT videos from one, LHT videos from another, and BCT + LHT videos from the remaining randomized group, as shown in Table [1](#brb3445-tbl-0001){ref-type="table-wrap"}. Each rating video was assessed by three neurologists with different grades of experience ranging from 0.5 to 20 years. Therefore, there were nine raters judging the videos. All of the raters were naive regarding medical history and clinical, laboratory and imaging data of each patient or control. Based on the videos the raters had to decide, if there was a paresis, on which side and of which grade (5, 4+, 4, 3). The videos were shown to each physician independently and in isolation.

###### 

Compilation of rating videos for analysis

              Rating video no. 1   Rating video no. 2   Rating video no. 3
  ----------- -------------------- -------------------- --------------------
  BCT         Group 1              Group 2              Group 3
  LHT         Group 2              Group 3              Group 1
  BCT + LHT   Group 3              Group 1              Group 2

BCT, bed cycling test; LHT, leg holding test in supine position.
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Each participant was assigned to the corresponding group by screening for study, according to the inclusion and exclusion criteria. Furthermore, the patients were examined and the grade of paresis was specified according to clinical criteria. The study was conducted prospectively with a recruitment period of 30 months (2011--2014).

Patient group {#brb3445-sec-0009}
-------------

Subjects met the following inclusion criteria: (1) age ≥ 18 years; (2) evidence of an unilateral focal lesion in the computed tomography (CT) or magnetic resonance imaging (MRI); (3) paresis of the lower extremity with a muscle strength grade ≥ 3/5. Patients with the following criteria were excluded: (1) age \< 18 years; (2) imaging showed lesions in the cerebellum or diffuse cerebral lesions; (3) patients with preexisting gait disturbance; (4) patients with disturbance of mobility/strength of the limb due to other and/or preexisting causes; (5) patients showing paresis of the lower extremity with a muscle strength grade (MRC grade) \< 3/5; and (6) patients who were not able to give their consent in the study design.

Control group {#brb3445-sec-0010}
-------------

Healthy control persons were recruited in the German Center for Vertigo and Balance disorders and in the neurological clinic. Clinical routine imaging had to exclude a focal cerebral lesion (by CT or MRI). Exclusion criteria for the control group were the following: (1) age \< 18 years old; (2) Patients who were not able to give their consent in the study design; (3) preexisting gait disturbance; and (4) preexisting disturbance of mobility/strength of the extremities.

Ethic standard protocol approvals, registration and patient consent {#brb3445-sec-0011}
-------------------------------------------------------------------

Approval from the ethics committee board of the University of Munich was obtained for the study. Written informed consent was obtained from all participants (controls and patients). All clinical investigations were conducted according to the principles of the Declaration of Helsinki. Every patient and control person confirmed the use of the anonymized videos for analysis and publication.

Statistical analysis {#brb3445-sec-0012}
--------------------

Data were collected using Excel (Microsoft, Redmond, WA) spreadsheet software. Statistical analysis was performed using R version 3.1 ([www.r-project.org](http://www.r-project.org)) with StatWeave ([homepage.stat.uiowa.edu/\~rlenth/StatWeave/](http://homepage.stat.uiowa.edu/~rlenth/StatWeave/)). The sensitivity, specificity, positive and negative predictive values (with exact confidence intervals) and likelihood ratios were calculated for each test. Differences were considered significant if *P* \< 0.05.

To assess inter‐rater reliability, Poisson regression was used to model the contingency tables between the three raters of each group with no paresis, left paresis, or right paresis as possible rating options. One additional parameter for the diagonal (representing agreement) was added, as a result of the model selection procedure using likelihood ratio tests. Since the three rater groups viewed different videos, one model was used for each rater group.

To assess the effect of rater experience, MRC grade, and test we modeled the odds to obtain a correct result (i.e., true positive or true negative) using a random effects logistic regression model (Bates D, Maechler M, Bolker B and Walker S \[2014\]. lme4: Linear mixed‐effects models using Eigen and S4\_. R package version 1.1‐7, <http://CRAN.R-project.org/package=lme4>) with a random intercept per patient, the confidence intervals were estimated using a parametric bootstrap.

Results {#brb3445-sec-0013}
=======

Patient group {#brb3445-sec-0014}
-------------

Sixty‐five patients were included, five had to be excluded for technical reasons. Sixty consecutive patients (26 females, mean age 68.4 ± 14.4 years) were examined. Clinical characteristics of the patients, including the details of the neurological examination are summarized in Tables [2](#brb3445-tbl-0002){ref-type="table-wrap"} and [3](#brb3445-tbl-0003){ref-type="table-wrap"}. Most of the patients (98.3%) had symptoms due to an acute event (ischemia or hemorrhage), only one patient was suffering from a tumor. Eighty percent of lesions were located supratentorially, mostly represented by the mid cerebral artery territory. Supplemental material online only shows patient no. 5 with a paresis on the right site (Video S2) and patient no. 40 with a paresis on the left site (Video S3). For more detailed information about the anatomical localization of the lesion, see Table [4](#brb3445-tbl-0004){ref-type="table-wrap"}.

###### 

Summary of clinical data of patients

  Clinical data of patients                       Total number of patients
  ----------------------------------------------- --------------------------------------------
  Etiology                                        
  Ischemia                                        56
  Hemorrhage                                      3
  Tumor                                           1
  Lesion location                                 
  MCA                                             43
  ACA                                             3
  PCA                                             2
  Mesencephalon                                   5
  Pons                                            5
  Medulla oblongata                               1
  Side of lesion                                  
  Left                                            24
  Right                                           36
  Onset of symptoms                               
  Up to 72 h                                      29
  72 h up to 3 months                             24
  More than 3 months                              7
  Graduation of paresis (muscle strength grade)   
  3/5                                             10
  4/5                                             50
  Leg holding test in supine position             
  Pathological                                    38 (17 left/21 right)
  Not pathological                                20
  Both sides/not evaluable                        0
  Bed cycling test forwards                       
  Pathological                                    57 (31 left/26 right)
  Not pathological                                3
  Both sides/not evaluable                        0
  Bed cycling test backwards                      
  Pathological                                    56 (32 left/24 right)
  Not pathological                                2
  Both sides/not evaluable                        0
  Heel‐knee test                                  
  Pathological                                    39 (19 left/20 right)
  Not pathological                                15
  Both sides/not evaluable                        0
  5‐m walk                                        
  Pathological                                    36
  Not pathological                                9
  Both sides/not evaluable                        15 (not feasible/patient not able to walk)
  Muscle tone lower limb                          
  Pathological                                    5 (1 left/4 right)
  Not pathological                                54
  Both sides/not evaluable                        0
  Reflexes                                        
  Pathological                                    6
  Not pathological                                54
  Both sides/not evaluable                        0
  Babinksi\'s sign                                
  Pathological                                    16 (8 left/8 right)
  Not pathological                                44
  Both sides/not evaluable                        0
  Sensibility                                     
  Pathological                                    14
  Not pathological                                46
  Both sides/not evaluable                        0

MCA, mid cerebral artery; ACA, anterior cerebral artery; PCA, posterior cerebral artery.
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###### 

Clinical data of patients

  Patient no.   Age   Sex      Onset of symptoms      Etiology   Lesion location   Side of lesion   Graduation of paresis   LHT        BCT forwards   BCT backwards   Babinski sign   5‐m walk       Sensibility   Reflexes   Heel‐knee test
  ------------- ----- -------- ---------------------- ---------- ----------------- ---------------- ----------------------- ---------- -------------- --------------- --------------- -------------- ------------- ---------- ----------------
  1             81    Male     72 ho up to 3 months   1          1                 Right            4                       \+ left    \+ left        \+ left         −               \+             −             −          \+ left
  2             55    Male     Up to 72 h             1          1                 Right            3                       \+ left    \+ left        \+ left         \+ left         Not feasible   \+            \+         \+ left
  3             73    Female   Up to 72 h             1          1                 Left             3                       \+ right   \+ right       \+ right        \+ right        \+             −             −          \+ right
  4             82    Female   Up to 72 h             1          1                 Right            4                       \+ left    \+ left        \+ left         −               \+             −             −          \+ left
  5             82    Male     Up to 72 h             1          1                 Left             4                       −          −              \+ right        −               −              −             −          \+ right
  6             92    Female   72 h up to 3 months    1          1                 Right            4                       \+ left    \+ left        \+ left         \+ left         \+             −             −          \+ left
  7             73    Female   72 h up to 3 months    1          1                 Right            3                       −/+ both   \+ left        \+ left         \+ left         Not feasible   \+            \+         Not feasible
  8             66    Female   72 h up to 3 months    1          1                 Right            4                       \+ left    \+ left        \+ left         −               \+             \+            −          \+ left
  9             54    Female   72 h up to 3 months    1          1                 Left             4                       \+ right   \+ right       \+ right        −               \+             −             −          −
  10            78    Female   72 h up to 3 months    2          4                 Right            3                       \+ left    \+ left        \+ left         −               Not feasible   −             −          Not feasible
  11            62    Male     72 h up to 3 months    1          1                 Right            4                       \+ left    \+ left        \+ left         −               \+             −             −          \+ left
  12            79    Female   72 h up to 3 months    1          5                 Right            4                       \+ right   \+ right       \+ right        −               \+             \+            −          \+ right
  13            71    Male     72 h up to 3 months    1          1                 Left             4                       −          \+ right       \+ right        \+ right        \+             −             −          \+ right
  14            47    Male     Up to 72 h             1          1                 Left             4                       −          \+ right       \+ right        \+ right        −              −             −          \+ right
  15            55    Male     72 h up to 3 months    1          5                 Left             4                       \+ right   \+ right       \+ right        \+ right        \+             \+            −          \+ right
  16            86    Female   Up to 72 h             1          1                 Left             4                       \+ right   \+ right       \+ right        −               \+             −             −          \+ right
  17            78    Female   72 h up to 3 months    1          1                 Right            4                       \+ left    \+ left        \+ left         −               \+             −             −          −
  18            62    Male     72 h up to 3 months    2          1                 Left             3                       \+ right   \+ right       \+ right        −               Not feasible   −             −          \+ right
  19            72    Female   72 h up to 3 months    1          1                 Left             4                       \+ right   \+ right       \+ right        \+ right        \+             −             −          −
  20            87    Female   72 h up to 3 months    1          1                 Right            4                       \+ left    \+ left        \+ left         −−              \+             −             −          −
  21            52    Male     Up to 72 h             2          4                 Right            4                       \+ left    \+ left        \+ left         −               Not feasible   \+            \+         \+ left
  22            38    Male     72 h up to 3 months    1          1                 Right            4                       −          \+ left        \+ left         \+ left         −              −             −          \+ left
  23            69    Male     72 h up to 3 months    1          3                 Right            4                       −          −              \+ left         −               −              −             −          −
  24            54    Male     72 h up to 3 months    1          5                 Left             4                       \+ right   \+ right       \+ right        \+ right        \+             −             −          \+ right
  25            68    Male     Up to 72 h             1          1                 Left             4                       \+ right   \+ right       \+ right        \+ right        \+             −             −          \+ right
  26            78    Female   Up to 72 h             1          1                 Left             4                       \+ right   \+ right       \+ right        −               \+             −             −          \+ right
  27            73    Female   72 h up to 3 months    1          1                 Right            3                       \+ left    \+ left        \+ left         −               \+             −             −          \+ left
  28            80    Female   72 h up to 3 months    1          1                 Left             4                       \+ right   \+ right       \+ right        −               \+             −             −          \+ right
  29            92    Male     Up to 72 h             1          1                 Right            3                       −          \+ left        \+ left         −               \+             \+            −          \+ left
  30            81    Male     72 h up to 3 months    1          4                 Left             4                       \+ right   \+ right       \+ right        −               Not feasible   −             −          \+ right
  31            34    Female   More than 3 months     1          6                 Right            4                       \+ right   \+ right       −               −               −              \+            −          −
  32            68    Female   Up to 72 h             1          1                 Left             4                       \+ right   \+ right       −               −               Not feasible   −             −          Not feasible
  33            68    Male     72 h up to 3 months    1          2                 Left             4                       \+ right   \+ right       \+ right        −               \+             −             −          \+ right
  34            74    Male     More than 3 months     1          1                 Left             4                       \+ right   \+ right       \+ right        −               \+             −             \+         \+ right
  35            80    Female   72 h up to 3 months    1          1                 Right            4                       −          \+ left        \+ left         −               \+             −             −          \+ left
  36            93    Male     Up to 72 h             1          1                 Right            4                       \+ left    \+ left        \+ left         \+ left         \+             −             −          \+ left
  37            68    Female   Up to 72 h             1          2                 Left             4                       \+ right   \+ right       −/+ both        −               Not feasible   −             −          −
  38            75    Male     Up to 72 h             1          1                 Right            4                       −          \+ left        \+ left         −               −              −             −          −
  39            81    Male     Up to 72 h             1          1                 Right            3                       −          \+ left        \+ left         \+ left         \+             −             −          \+ left
  40            21    Male     More than 3 months     3          1                 Right            4                       −          \+ left        \+ left         −               \+             −             −          \+ left
  41            72    Male     More than 3 months     1          1                 Left             4                       \+ right   \+ right       \+ right        −               \+             \+            \+         \+ right
  42            64    Female   Up to 72 h             1          5                 Right            4                       \+ left    \+ left        \+ left         −               Not feasible   \+            −          \+ left
  43            67    Male     Up to 72 h             1          1                 Left             3                       \+ right   \+ right       \+ right        −               Not feasible   −             −          \+ right
  44            43    Female   72 h up to 3 months    1          1                 Right            4                       −          \+ left        \+ left         −               −              −             −          −
  45            65    Male     Up to 72 h             1          1                 Right            4                       \+ left    \+ left        \+ left         −               \+             −             −          \+ left
  46            71    Male     Up to 72 h             1          2                 Right            3                       \+ left    \+ left        \+ right        −               \+             −             −          \+ right
  47            77    Female   Up to 72 h             1          1                 Right            4                       −          \+ left        \+ left         −               \+             \+            −          \+ left
  48            62    Male     Up to 72 h             1          3                 Right            4                       −          −              \+ left         −               \+             −             −          −
  49            74    Female   Up to 72 h             1          1                 Right            4                       −          \+ left        \+ left         −               \+             −             −          −
  50            68    Male     Up to 72 h             1          1                 Left             4                       \+ right   \+ right       \+ right        −               \+             −             −          \+ right
  51            72    Male     More than 3 months     1          2                 Right            4                       −          \+ left        \+ left         \+ left         \+             −             −          \+ both
  52            57    Female   Up to 72 h             1          4                 Right            4                       \+ right   \+ right       −/+ both        −               Not feasible   −             −          \+ right
  53            79    Female   Up to 72 h             1          4                 Right            4                       −          \+ left        \+ left         −               Not feasible   −             −          \+ both
  54            73    Male     Up to 72 h             1          1                 Left             4                       −          \+ right       \+ right        −               \+             −             −          −
  55            60    Male     More than 3 months     1          1                 Left             4                       −          \+ right       \+ right        −               \+             −             −          −
  56            54    Male     More than 3 months     1          1                 Right            4                       −/+ both   \+ left        \+ left         \+ right        Not feasible   −             −          \+ both
  57            67    Male     Up to 72 h             1          1                 Left             4                       −          \+ right       \+ right        −               −              \+            −          −
  58            73    Male     Up to 72 h             1          1                 Right            4                       −          \+ left        \+ left         −               −              \+            \+         −
  59            80    Female   Up to 72 h             1          4                 Right            4                       \+ left    \+ left        \+ left         \+ left         Not feasible   \+            −          \+ left
  60            41    Male     72 h up to 3 months    1          1                 Right            4                       \+ left    \+ left        \+ left         −               Not feasible   −             −          \+ left

Patient\'s characteristics, categorized by patient number, gender, age, onset of symptoms as well as etiology of symptoms, side of lesion. The graduation of paresis was performed using the oxford scale. According to Medical research council (MRC) scale (Palo Alto [1978](#brb3445-bib-0007){ref-type="ref"}; Paternostro‐Sluga et al. [2008](#brb3445-bib-0008){ref-type="ref"}). Muscle strength is graded 0 to 5 (3 = through full range actively against gravity, 4 = through full range actively against some resistance, 5 = through full range actively against strong resistance). + = pathological; − = not pathological/unremarkable. Etiology: 1 = ischemia, 2 = hemorrhage, 3 = tumor. Lesion location: 1 = supratentorial mid cerebral artery (MCA), 2* = *supratentorial *anterior* cerebral artery (ACA), 3 = supratentorial posterior cerebral artery (PCA), 4 = infratentorial mesencephalon/midbrain, 5 = infratentorial pons/brainstem, 6 = infratentorial medulla oblongata/brainstem.

BCT, bed cycling test; LHT, leg holding test in supine position.
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###### 

Detailed anatomical description of involved structures in patient group

  Patient no.   Age   Side of lesion   Graduation of paresis   Anatomical location of lesion
  ------------- ----- ---------------- ----------------------- ---------------------------------------------------------------------------------------------------------------------------------------------
  1             81    Right            4                       Lateral lenticulostriate artery infarction
  2             55    Right            3                       Lateral lenticulostriate artery infarction
  3             73    Left             3                       Post‐ and subcentral media infarction including posterior insula
  4             82    Right            4                       Lateral lenticulostriate artery infarction
  5             82    Left             4                       Gyrus postcentralis
  6             92    Right            4                       Gyrus praecentralis/Sulcus centralis
  7             73    Right            3                       Medial and lateral lenticulostriate artery infarction
  8             66    Right            4                       Gyrus praecentralis and postcentralis
  9             54    Left             4                       Media infarction, superior division
  10            78    Right            3                       Basal ganglia hemorrhage
  11            62    Right            4                       Capsula externa and Nucleus caudatus right
  12            79    Right            4                       Paramedian pons infarction
  13            71    Left             4                       Putamen and posterior insular region
  14            47    Left             4                       Corpus ncl. Caudatus
  15            55    Left             4                       Paramedian ponst infarction
  16            86    Left             4                       Posterioren Gyrus frontalis medius, Gyrus praecentralis and postcentralis
  17            78    Right            4                       Lateral lenticulostriate artery infarction
  18            62    Left             3                       Hemorrhage capsula interna (thalamus/crus posterior)
  19            72    Left             4                       Corona radiata parietal, temporal (multiple, embolic)
  20            87    Right            4                       Cortical border zone infarction between MCA und PCA
  21            52    Right            4                       Basal ganglia hemorrhage
  22            38    Right            4                       2/3 MCA territory infarction frontal, temporal, insular region and putamen (dorsolateral)
  23            69    Right            4                       Posterior infarction
  24            54    Left             4                       Paramedian pons infarction
  25            68    Left             4                       Infarction of Capsula interna (Crus posterior)
  26            78    Left             4                       Capsula externa, posterior insula
  27            73    Right            3                       Anterior Choroideal artery
  28            80    Left             4                       Anterior Choroideal artery
  29            92    Right            3                       Lateral lenticulostriate artery infarction
  30            81    Left             4                       Thalamus
  31            34    Right            4                       Medulla oblongata (dorsolateral)
  32            68    Left             4                       MCA‐territory (posterior division)
  33            68    Left             4                       ACA‐infarction
  34            74    Left             4                       Capsula interna
  35            80    Right            4                       Lobus temporalis, basal ganglia, Cortical (MCA territory)
  36            93    Right            4                       MCA territory, pericentral region, cortical border zone (multiple, embolic)
  37            68    Left             4                       ACA‐infarction
  38            75    Right            4                       Corona radiata
  39            81    Right            3                       Putaman dorsal and posterior insular region
  40            21    Right            4                       Resection of a meduloblastoma occipital
  41            72    Left             4                       Basal ganglia
  42            64    Right            4                       Pons infarction anterolateral
  43            67    Left             3                       MCA territory (multiple, embolic)
  44            43    Right            4                       Cortical border zone infarction
  45            65    Right            4                       Cortical border zone infarction
  46            71    Right            3                       ACA‐infarction right and PICA
  47            77    Right            4                       Lacunar infarction basal ganglia
  48            62    Right            4                       Thalamus medial (PCA territory, multiple embolic)
  49            74    Right            4                       MCA territory, Gyrus praecentralis, insular region posterior (multiple, embolic)
  50            68    Left             4                       Lateral lenticulostriate artery infarction (multiple, embolic)
  51            72    Right            4                       Lacunar infarction white matter media territory
  52            57    Right            4                       Paramedian pons infarction
  53            79    Right            4                       Basal ganglia
  54            73    Left             4                       MCA territory (posterior insular region, basal ganglia, multiple, embolic)
  55            60    Left             4                       Capsula interna
  56            54    Right            4                       Lateral and medial lenticulostriate artery infarction (basal ganglia)
  57            67    Left             4                       Cortical border infarction
  58            73    Right            4                       Gyrus praecentralis (multiple embolic)
  59            80    Right            4                       Thalamus dorsolateral
  60            41    Right            4                       MCA territory (Gyrus praecentralis, postcentralis, Lobus parietalis super, insular region, operculum frontal and temporal, corpus caudatus)

MCA, mid cerebral artery; ACA, anterior cerebral artery; PCA, posterior cerebral artery.
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Control group {#brb3445-sec-0015}
-------------

Sixty‐two healthy control persons were enrolled, two had to be excluded for technical reasons, 60 subjects were analyzed (38 females, mean age 57.3 ± 18.6). Supplemental material online only shows a control person performing the leg holding test and BCT (see Video S1).

Sensitivity, specificity, positive predictive value and negative predictive value of the BCT and LHT {#brb3445-sec-0016}
----------------------------------------------------------------------------------------------------

The sensitivity and specificity of performing the single execution of each test were 0.64 (95% CI 0.57--0.71) and 0.70 (0.63--0.77) for the BCT only, 0.46 (0.39--0.54), and 0.86 (0.80--0.90) for the LHT only and 0.68 (0.61--0.75) and 0.78 (0.72--0.84) for BCT and LHT together. The positive and negative predictive values were 0.68 (0.60--0.74) and 0.67 (0.60--0.74) for the BCT only, 0.76 (0.67--0.84) and 0.62 (0.56--0.68) for the LHT only and 0.76 (0.69--0.82) and 0.72 (0.65--0.78) for both tests. For details see Table [5](#brb3445-tbl-0005){ref-type="table-wrap"}. The positive and negative likelihood ratios were 2.2 and 2.0 for the BCT, 3.2 and 1.6 for the LHT, and 3.2 and 2.5 for both tests together.

###### 

Test properties of bed cycling test, leg holding test and performing both clinical tests together. Values are expressed as mean and 95% confidence interval (range)

                BCT                 Leg holding test    Both clinical tests
  ------------- ------------------- ------------------- ---------------------
  Sensitivity   0.64 (0.57--0.71)   0.42 (0.38--0.54)   0.68 (0.61--0.75)
  Specificity   0.70 (0.63--0.77)   0.85 (0.80--0.90)   0.78 (0.72--0.84)
  PPV           0.68 (0.60--0.74)   0.76 (0.67--0.84)   0.76 (0.69--0.82)
  NPV           0.67 (0.60--0.74)   0.62 (0.57--0.68)   0.72 (0.65--0.78)

BCT: bed cycling test; PPV: positive predictive value; NPV: negative predictive value.
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Comparison of inter‐rater reliability {#brb3445-sec-0017}
-------------------------------------

From the observed numbers of agreements (po) and the Poisson model estimates (beta_diag) Aickin\'s alpha was computed \[alpha = po (1 − e^−beta_diag^) as 0.54, 0.55, and 0.54 for rater groups 1--3\].

Results regarding the different clinical experience {#brb3445-sec-0018}
---------------------------------------------------

Clinical experience (three categories \<2 years, 2--6 years, more than 6 years) did not show a significant effect on the odds of a correct test result. This also held true, when the data set was confined to the BCT only. Compared to a grade 3 paresis the odds for a correct test result was considerably lower for a grade 4 (OR = 0.0385, 95% CI 0.0057--0.1149)), and a grade 5 (OR = 0.1578 (0.0228; 0.4436) paresis. The odds for a correct test result were not significantly higher (1.083, 95% CI 0.7470--1.545) for the BCT than for the LHT, however the OR was 1.653, 95% CI 1.155--2.507 for both tests.

Discussion {#brb3445-sec-0019}
==========

The major findings of this prospective observer‐blinded diagnostic study are that the BCT (63.3%) showed a higher sensitivity compared to the LHT (46.2%), while the LHT was more specific. In the case of a positive LHT, an additional BCT does not provide further valid diagnostic information. In the case of a negative LHT, however, adding a BCT results in a better diagnostic accuracy. The combination of both clinical tests shows the highest sensitivity of 68.4%. In the case of a negative result of the LHT, the additional implementation of the BCT provides further information. This means, that more cerebral lesions can be detected by performing both -- the LHT and the BCT. This combination is the most sensitive and time‐efficient method for detecting subtle lesions of the lower limb and could be a very useful and important tool in the evaluation of patients with possible neurological diseases for every emergency physician. The similarity of Aickin\'s alpha among the rater groups supports the robustness of our results regarding inter‐rater reliability.

In several other recent studies the sensitivity and specificity of known clinical tests have been evaluated. The main emphasis was, however, on the upper limb. A normal leg holding test (Mingazzini test) was reliable to rule out a motor lesions (Teitelbaum et al. [2002](#brb3445-bib-0010){ref-type="ref"}). A total of 164 patients who held the maneuver for an average of 10 sec was analyzed showing a sensitivity of 55.4% and specificity of 87.5% (Teitelbaum et al. [2002](#brb3445-bib-0010){ref-type="ref"}). Other studies regarding the clinical relevance of the clinical investigation of the lower limb are missing, especially there are no other studies regarding the sensitivity and specificity of the tests. In our study with a total of 120 participants we again could demonstrate the sensitivity (46.20%) and specificity (85.83%) of the leg holding test in supine position -- our results are therefore very similar to those described in the literature (Teitelbaum et al. [2002](#brb3445-bib-0010){ref-type="ref"}).

One problem of the leg holding maneuver in supine position is that not many patients, especially patients with weak abdominal muscles, are able to perform it properly. In our study we observed that it was easier for patients, especially elderly and obese patients, to perform the BCT.

Of course, we are aware of the limitations of our study: It is quite difficult to blind examiners to the diagnosis in studies on the effectiveness of clinical signs. We attempted this by including a control group using nine different observers with different levels of clinical practice and by showing the BCT, the LHT and both clinical tests to different examiners. The observers were blinded to the history of the patients. However, we cannot rule out the possibility that the observers detected subtle clues that identified patients as having a focal lesion. Moreover, different observers can of course interpret the clinical maneuvers differently.

Secondly, all patients had variable hemiparesis (graded MRC 3 or 4). Moreover, patients with sensory abnormalities that could affect testing were not excluded.

Thirdly, most of our patients with clinical signs had a cerebrovascular disease, only one suffered from a neoplastic focal brain disease. As a result, most of the participants in the patient group had an acute disease.

The BCT mostly detects proximal paresis of the legs as the innervation of the BCT activates proximal muscles of the hip and the leg. While forearm rolling can be considered as more distal motor function, distal paresis of the legs needs further clinical evaluations. Foot tapping test could be a possible addition to the clinical examination. Therefore, the task is performed mostly by distal muscles, which are related to voluntary, discrete and skilled movements (Numasawa et al. [2012](#brb3445-bib-0006){ref-type="ref"}). So the importance of distal paresis needs further clinical evaluation. On the other hand, the BCT is a sensitive test for the evaluation of paresis of the lower limb. It is of importance to note that self‐paced voluntary rhythmic movements demand the participation of several central motor and sensory areas. Apart from superficial and deep sensory deficit that could lead to a pathological performance of the BCT, the appearance of foot apraxia or even ataxia may have an impact on this rhythmic movements and therefore to a pathological performance. However, this could be a factor that led to the limited specificity of the BCT.

Finally, it should not be forgotten that in the context of a clinical trial, aspects of the clinical examination and signs could be over‐interpreted. Moreover, the assessment of the "right" graduation of the paresis seems difficult for the evaluators because they can only see the LHT and the BCT.

A strength of the study is the inclusion of raters with different levels of clinical experience from 0.5 to 20 years. The study identified no significant effect of rater experience on the validity of the two tests examined, which makes them simple, non‐invasive, and yet valuable diagnostic tools for clinicians with less experience as well.

Conclusions {#brb3445-sec-0020}
===========

The physical examination is the most important guide in neurology for the further diagnosis of patients with focal neurological deficits. Therefore, we suggest that the clinical examination of the lower limb be expanded to include the BCT on a routine basis in all patients with possible central motor dysfunctions. The implementation of the BCT may also help to detect focal lesions when used by non‐neurologists, but this would need to be analyzed in a separate study.
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###### 

**Video S1**. Showing a healthy control person performing the leg holding test in the supine position and the bed cycling test.

###### 

Click here for additional data file.

###### 

**Video S2**. Showing patient no. 5 with a paresis on the right site, graduated in clinical examination MRC 4/5.

###### 

Click here for additional data file.

###### 

**Video S3**. Showing patient no. 40 with a paresis on the left site, graduated in clinical examination MRC 4/5.

###### 

Click here for additional data file.
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